Specifically, we have identified that exposure of ASCs to iAs aberrantly modulates TGFβ signaling, a pathway strongly linked with the regulation of prostate cancer progression (Li et al. 2008; Santamaria-Martínez et al. 2009). The gene discussed is TGFB1; the disease is prostate cancer.